Streetbeat News

Revenues

GILD

RCUS

Gilead Sciences and Arcus Biosciences announced that their combination therapy significantly reduced the risk of death and disease progression in third-line metastatic colorectal cancer patients in a Phase 1b/2 trial. The results will be presented at the 2024 ASCO Annual Meeting.

Portfolio Pulse from Charles Gross

June 02, 2024 | 2:36 pm

LI

NIO

TSLA

XPEV

Chinese EV makers Nio, XPeng, and Li Auto reported strong deliveries in May, with Nio and Li Auto setting record numbers. This comes amid a competitive market where Tesla is struggling to maintain its sales despite price cuts.

Portfolio Pulse from Shanthi Rexaline

June 01, 2024 | 3:17 pm

MSFT

NVDA

South Korean traders are increasingly interested in AI-linked digital assets, with the country's share of global trading volumes for Nvidia Corp.'s AI-linked tokens rising significantly. Nvidia and Microsoft are among the most popular overseas stocks in South Korea. Despite the enthusiasm, there are concerns about the sustainability of interest in AI-linked crypto projects.

Portfolio Pulse from Rounak Jain

June 01, 2024 | 1:36 pm

CDW

CDW (NASDAQ:CDW) has outperformed the market over the past 5 years with an average annual return of 16.89%, resulting in a $100 investment growing to $225.06. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 9:30 pm

LIN

Linde (NASDAQ:LIN) has outperformed the market over the past 20 years with an average annual return of 13.0%, surpassing the market by 5.08% annually. A $1000 investment in LIN 20 years ago would be worth $11,467.09 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 9:30 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years with an average annual return of 16.92%, significantly higher than the market average. A $1000 investment in TMO 10 years ago would be worth $4,822.38 today.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 9:00 pm

VKTX

Viking Therapeutics (NASDAQ:VKTX) has significantly outperformed the market over the past 5 years, with an average annual return of 50.59%. A $1000 investment in VKTX 5 years ago would now be worth $8,117.34. The company's current market capitalization is $6.86 billion.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 9:00 pm

RICK

RCI Hospitality Holdings (NASDAQ:RICK) experienced significant stock volatility following allegations of raids at its locations by Bear Cave Research's Edwin Dorsey. The stock fell on Thursday but rebounded on Friday. Dorsey claims that a photo shows a raid at Rick's NYC location and suggests other locations may have been raided. RCI's CEO Eric Langan has not commented publicly. The company has faced challenges with its restaurant concept, NFT project, and regulations. RCI's recent earnings missed estimates.

Portfolio Pulse from Chris Katje

May 31, 2024 | 8:38 pm

COIN

Cryptocurrency markets experienced sideways trading with Bitcoin, Ethereum, and Dogecoin showing minimal price changes. Liquidations decreased by 15% and trading volume was down by 5%. Analysts predict continued sideways movement for Bitcoin, while Ethereum could see significant gains by year-end. Coinbase's trading revenue is under pressure due to crypto market maturity.

Portfolio Pulse from Ivan Crnogatić

May 31, 2024 | 8:34 pm

HWM

Howmet Aerospace (NYSE:HWM) has significantly outperformed the market over the past 5 years, delivering an average annual return of 37.4%. A $100 investment in HWM 5 years ago would now be worth $499.26. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 8:30 pm